0001161582
false
0001161582
2022-06-23
2022-06-23
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report:
(Date of earliest event reported)
June 23, 2022 (November 5, 2021)
____________________________
GROWLIFE,
INC.
(Exact name of registrant as specified in charter)
Delaware
(State or other Jurisdiction of Incorporation or Organization)
|
000-50385
(Commission File Number) |
|
90-0821083
(IRS Employer Identification No.) |
| |
11335
NE 122nd Way, Suite 105
Kirkland,
WA 98034
(Address of Principal Executive Offices and zip code) |
|
(866)
781-5559
(Registrant’s telephone number, including area
code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of registrant under any of the following provisions:
☐ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On June 17, 2022, the Board of Directors (the “Board”)
of GrowLife, Inc. (the “Company”) approved the implementation of a one-for-one hundred and fifty (1:150) reverse stock split
of all of the Company’s issued and outstanding common stock (the “Reverse Stock Split”), as of the Record Date of June
17, 2022.
The Reverse Stock Split was previously approved by
the Company’s shareholders at the Company’s November 5, 2021 annual meeting of stockholders. The approvals provided discretion
to the Board to implement the Reverse Stock Split any time prior to September 1, 2022.
As a result of the Reverse Stock Split, every one
hundred and fifty (150) shares of the issued and outstanding common stock of the Company will be converted into one (1) share of common
stock. Any and all fractional shares resulting from the Reverse Split which are less than 1 (one) whole share, shall not be rounded up
to the next whole share and rather such Holder shall receive a fractional pro-rata cash payment equal to 120% of the closing market price
on June 17, 2022. Any and all fractional shares created by the Reverse Stock Split which are greater than one (1) whole share will
be rounded up to the nearest whole share.
The number of authorized shares will not change as
a result of the Reverse Stock Split.
The Reverse Stock Split will become effective
upon announcement by FINRA (the Financial Industry Regulatory Authority). In connection with the Reverse Stock Split, the
Company’s CUSIP number will change.
An amendment to Articles of Incorporation will also
be filed citing the Reverse Stock Split.
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
GROWLIFE, INC. |
| |
|
|
| Date: June 23, 2022 |
By: |
/s/ Marco Hegyi |
| |
|
Marco Hegyi |
| |
|
Chief Executive Officer |
- 2 -
